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Abstract This article explores the history of the preconcep-
tion movement in the United States and the current status of
professional practice guidelines and standards. Profession-
als with varying backgrounds (nurses, nurse practitioners,
family practice physicians, pediatricians, nurse midwives,
obstetricians/gynecologists) are in a position to provide pre-
conception health services; standards and guidelines for nu-
merous professional organizations, therefore, are explored.
The professional nursing organization with the most highly
developed preconception health standards is the American
Academy of Nurse Midwives (ACNM); for physicians, it is
the American College of Obstetricians and Gynecologists
(ACOG). These guidelines and standards are discussed in
detail.
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Introduction
From the earliest recorded time, women have been advised
to increase their level of wellness and to avoid hazardous
substances before becoming pregnant. Plutarch wrote that
the ancient Spartans: “. . .ordered the maidens to exercise
themselves with wrestling, running, throwing the quoit and
casting the dart, to the end that the fruit they conceived
might, in strong and healthy bodies, take firmer root and find
better growth” [1]. In the Old Testament [2], the following
passage appears: “And the angel of the Lord appeared unto
the woman, and said unto her, ‘Behold now thou art barren,
and bearest not: but thou shalt conceive and bear a son. Now,
therefore beware, I pray thee, and drink not wine and strong
drink, and eat not any unclean thing.’ ”
As the modern practice of obstetrics evolved, it became
a specialty that separated women’s prepregnancy wellness
from prenatal care, but in the last quarter century this has
begun to change. The dominant model of prenatal care as
the main perinatal prevention strategy has been reexamined,
and recognition of the importance of the prepregnancy pe-
riod has emerged. Today the general public and health care
professionals could easily be overwhelmed by the amount of
information available which promotes prepregnancy or pre-
conceptional health. A Google search (conducted April 25,
2005) of the term “preconception health” identified 630,000
hits. On the same day a search of the National Library of
Medicine’s PubMed found 338 entries for “preconception
health” with the earliest published in 1978, and 103 ar-
ticles for “preconceptional” with the earliest published in
1982; in addition, most of the articles identified through
the two search terms were unique. The nation’s approach
to women’s health care may well be at the tipping point
of redefining the perinatal period to include women’s well-
ness across the reproductive life span as an appropriate
Springer
S44 Matern Child Health J (2006) 10:S43–S52
and favored approach to impacting reducing poor pregnancy
outcomes.
Stimulated by research findings which underscored the
limitations of traditional prenatal care on decreasing the inci-
dence of congenital anomalies, leaders in the health commu-
nity, professional organizations, advocacy groups and federal
government began actively encouraging redefinition of the
United States’ perinatal prevention paradigm in the early
1980s. Because the usual pathways to impact on perinatal
outcomes (prenatal and neonatal care) often start too late
to achieve primary prevention, the need to reach women
with prevention opportunities before prenatal care was rec-
ognized and the concept of preconceptional health promotion
emerged. This article explores the history of the preconcep-
tion movement in the United States and the current status of
professional practice guidelines and standards.
The decade of the eighties
One of the first federal position papers to acknowledge the
need to change the nation’s approach to prevention appeared
in 1979; while focused on the need to develop a continuum
of child health care, it included the concept of prepregnancy
care [3]. The programmatic elements in the proposed com-




 Child Health care
 Services for handicapped children
 Adolescent services
Interest in moving away from categorical care to more
integrated and comprehensive services has subsequently be-
come a hallmark of current efforts to redefine the perinatal
prevention paradigm. Why the list employed the word “inter-
conceptional” rather than preconceptional is not clear. Since
1979, “interconceptional” care has come to represent efforts
to address health status between pregnancies, birth spacing
and intendedness of subsequent conceptions; “preconcep-
tional” generally refers to the woman’s health status and
risks before the first pregnancy and her health status shortly
before any conception. “Periconceptional” usually refers to
the time immediately before conception through the period
of organogenesis. It is important to note that this nomencla-
ture is inconsistently applied and not universally accepted.
In England, for instance, “preconceptional” is referred to as
“preconceptual.”
By 1985, the concept of preconceptional care and its po-
tential advantages began to gain momentum. In that year, the
Institute of Medicine published Preventing Low Birthweight
[4] and noted that numerous opportunities exist before preg-
nancy to reduce the incidence of low birth weight, but that
they are too often overlooked in favor of interventions dur-
ing pregnancy. The Committee emphasized the importance
of prepregnancy risk identification, counseling and risk re-
duction; health education related to pregnancy outcome in
general, and to low birthweight, in particular. The Committee
supported restructuring the perinatal prevention paradigm by
noting:
“Much of the literature about preventing low birthweight
focuses on the period of pregnancy—how to improve the
content of prenatal care, how to motivate women to reduce
risky habits while pregnant, how to encourage women to
seek out and remain in prenatal care. By contrast, lit-
tle attention is given to opportunities for prevention be-
fore pregnancy. Only casual attention has been given to
the proposition that one of the best protections available
against low birthweight and other poor pregnancy out-
comes is to have a woman actively plan for pregnancy,
enter pregnancy in good health with as few risk factors
as possibly, and be fully informed about her reproductive
and general health.” (p. 119)
The IOM Committee advocated that family planning ser-
vices be positioned as an essential component of effective
preconceptional initiatives, thereby supporting the integra-
tion of services rather than reinforcing firm boundaries of
categorical programs. It also recommended that the con-
tent of reproductive health education, particularly in schools
and family planning settings, be expanded to introduce con-
cepts of prepregnancy wellness. The third recommendation
of the Committee was to develop the notion of preconcep-
tional consultation to identify and reduce risks associated
with poor pregnancy outcomes, particularly for women who
had already experienced a poor outcome.
In 1989 another federally appointed committee, The Ex-
pert Panel on the Content of Prenatal Care, gave a strong en-
dorsement to preconceptional health when it recommended
that the preconception visit may be the single most important
health care visit when viewed in the context of its effect on
pregnancy [5]. The Panel went on to suggest that the last
family planning visit should be the preconception visit and
that the concept of preconception care should become a rou-
tine part of prenatal care with accompanying reimbursement
and coverage included in all health insurance plans. How-
ever, the Panel indicated that preconception care is likely
to be most effective when services are provided as part of
general preventive care or during primary care visits for
medical conditions. This approach has come to be referred
to as “opportunistic care” because it takes advantage of the
opportunities afforded by visits for other reasons.
Specific components of preconception care were identi-
fied by the Panel as (1) risk assessment, (2) health promotion
and (3) intervention and follow-up. The Panel advocated
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that the preconception assessment include a holistic range
of investigations including: individual and social conditions,
adverse health behaviors, medical, psychological and envi-
ronmental conditions and barriers to family planning and
early prenatal care enrollment.
In 1983, the American Academy of Pediatrics (AAP)
and the American College of Obstetrics and Gynecologists
(ACOG) in partnership with the March of Dimes Birth
Defects Foundation published the first Guidelines for
Perinatal Care [6]. Appendix C of those first guidelines
notes that “Preparation for parenthood should begin prior
to conception. At the time of conception the couple should
be in optimal physical health and emotionally prepared for
parenthood” (p. 257). The Guidelines indicated that when
pregnancy is contemplated, the preconception visit should
be part of a comprehensive gynecologic examination, and
the history should include a detailed family history includ-
ing ethnic background as well as investigation of lifestyle
issues, religion, the home and work environments, hobbies,
pets, immunizations, medications and dietary habits. The
guidelines recommended use of an extensive checklist to
systematically explore areas of potential significance. Based
on the patient’s history, the “counseling and instruction
session” could be focused in a variety of directions including
testing for genetically transmitted diseases and the parent’s
carrier status, as well as counseling regarding potential
teratogenic exposures, exploration and interventions to
address medical problems prior to pregnancy, interconcep-
tional care to address the likelihood of recurrence of any
complications experienced in previous pregnancies, includ-
ing congenital anomalies, and the importance of recording
menstrual dates to allow the earliest possible initiation
of prenatal care.
In 1985, ACOG provided a small grant to Moos and Ce-
falo to develop and test a checklist which came to be known
as the preconceptional health appraisal [7, 8]. The appraisal
was designed to aid providers in conducting comprehen-
sive screening for preconceptional risks in a time-efficient
manner and employed a self-assessment tool with built-in
educational feedback. First introduced into local health de-
partment family planning clinics in North Carolina, it was
adopted over the next several years by numerous state health
departments across the country as well as private providers,
large health maintenance organizations and several Canadian
provinces. The commitment of public health organizations to
introduce women to the concepts of preconceptional health
during routine family planning visits placed the public sector
in the position of being a leading innovator in the precon-
ception movement. One state that demonstrated particular
commitment to changing the perinatal prevention paradigm
was Wisconsin. By the mid-1980’s, the Wisconsin Associ-
ation for Perinatal Care was calling for redefinition of peri-
natal care to include the preconceptional period [9], and it
has been unwavering in its commitment to improve preg-
nancy outcomes through preconceptional health promotion
strategies ever since.
Concurrent with the above noted activities, additional cre-
dence to the benefits of preconceptional health promotion
and primary prevention was provided when two nationally
recognized obstetrician-gynecologists published books on
the topic, one for the professional community and one for
the consumer market [7, 10].
The decade of the nineties
Healthy People 2000, the national health promotion and dis-
ease prevention objectives for the United States, published
in 1990, moved preconceptional care into a standard expec-
tation within the health care system when it defined it as
a one of its service and protection objectives. The specific
objective reads:
 Increase to at least 60% the proportion of primary care
providers who provide age-appropriate preconception care
and counseling (p. 199)
Supporting rationale for the objective states that “the pur-
pose of preconception care and counseling is to ensure that
couples are healthy prior to pregnancy and prepared to as-
sume the responsibilities of parenthood, thereby reducing the
risk of poor pregnancy outcomes” (p. 199). The remainder
of the rationale not only echoes the position of the earlier
1989 Expert Panel on the Content of Prenatal Care regard-
ing the opportunities of preconception care to address many
medical conditions, personal behaviors and environmental
conditions [5] but also stresses preconceptional health pro-
motion as an opportunity to educate young people about
the risks of sexual activity, including unintended pregnan-
cies, disease-related infertility and cancers [11]. In 1993, the
March of Dimes Birth Defects Foundation published Toward
Improving the Outcome of Pregnancy: The 90s and Beyond
which introduced the concept of “reproductive awareness”
as the basic health promotion strategy needed to improve
pregnancy outcomes [12]. The document, often referred to
as TIOP, reflects the position of the March of Dimes’ Com-
mittee on Perinatal Health. Because awareness of reproduc-
tive risks, healthy behaviors and family planning options is
essential to improving the outcome of pregnancy, the com-
mittee declared that “a society-wide change in reproduc-
tive awareness is needed in the United States” (p. 12) and
called for “a new strategy to reach each woman of child-
bearing age with reproductive awareness messages at every
health encounter”(p. 12). The committee called upon health
care providers to move away from the expectation that the
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prevention of poor pregnancy outcomes is only the profes-
sional responsibility of obstetrical providers by noting:
“A woman’s health status in relationship to pregnancy
usually is not considered until the first prenatal visit, and
prenatal care often is segregated from other health care
by provider type and by payment mechanism. Yet women
of childbearing age have many encounters with the health
care system. These include visits to gynecologists, pe-
diatricians, internists, family physicians, nurse midwives
and nurse practitioners, in settings such as public health,
school health, women’s health, substance abuse treatment,
family planning, and sexually transmitted disease clinics
and private offices (p. 13).”
TIOP goes on to call for professional standards, structures
and financing to be set in place to ensure an annual pre-
conception or interconception risk reduction visit for every
woman from menarche to menopause and that a prepreg-
nancy planning visit become a standard component of ma-
ternity care, routinely available to all women and integrated
into the perinatal care delivery system. TIOP also stressed
that reproductive awareness is not sex or gender specific and
that the need to reach out to males, especially during the pre-
conception and interconception periods, requires thoughtful
and innovative strategies.
ACOG published its first technical bulletin on preconcep-
tion care in May, 1995 [13] The bulletin called for thorough
and systematic identification of risks, the provision of edu-
cation individualized to the patient’s needs, and the initiation
of any desired interventions. Risk identification was broadly
defined to include the areas of medical, reproductive, and
family histories, nutritional habits, drug and environmental
exposures and social issues and these efforts were to be tar-
geted at improving outcomes for both the mother and the fe-
tus ACOG took the position that rather than ensuring healthy
pregnancy outcomes as suggested by other position papers,
preconception care allows the woman and her partner, if so
desired, to make informed-decisions. It states:
“Once information is available, the patient can be in-
formed about the certainty or limitations of available in-
formation, what the risks of pregnancy may be, and pre-
cautions that may be beneficial. After women have been
informed of the increased risks pregnancy may pose to
their health or the health of a fetus or both, they can ac-
cept the increased risks, choose to modify their risks or
opt to avoid childbearing (p. 2).”
ACOG cautioned against over promising the benefits of
preconceptional care to both providers and patients by specif-
ically noting that preconceptional services do not guarantee
good pregnancy outcomes. It noted that placing emphasis
only on women who are planning their next conception or
women who have been identified as high-risk will result in a
significant number of missed opportunities for primary pre-
vention. Women who experience an unintended pregnancy
are at least as likely to have risk factors for poor pregnancy
outcomes as women who consciously plan the timing of their
pregnancy. Therefore, ACOG recommended that routine vis-
its by women who may, at some time, become pregnant are
important opportunities to emphasize the importance of pre-
conceptional health and habits and the advantages of planned
pregnancies. Finally, ACOG called for a coordinated mul-
tispecialty effort directed by the obstetrician-gynecologist
as a means to provide a comprehensive framework for
preconceptional health care for all women of childbearing
potential.
The current decade
In 2002, the fifth edition of the AAP/ACOG Guidelines for
Perinatal Care was published [14]. In the preceding editions,
preconception care had moved from an appendix item to the
main text in preceding editions. This latest edition, however,
reflects a shift away from framing preconceptional care as
appropriately targeted toward prospective parents who are
contemplating pregnancy to an emphasis on integration of
preconceptional health promotion into all health encounters
during a woman’s reproductive years.
While some efforts to operationalize a redefined perinatal
prevention paradigm grew, others dropped back. For exam-
ple, Healthy People 2010 eliminated preconceptional health
as a specific objective [15]. Except for the objective, “In-
crease the proportion of pregnancies begun with an optimum
folic acid level” (target: 80%), the relevance of a woman’s
health status at the time of conception to pregnancy out-
comes is not referenced in the document, and reliance on
prenatal and neonatal care to impact on pregnancy outcomes
is reinforced as the preferred strategy to meet the perinatal
objectives.
Evolving standards and guidelines from
professional organizations
As the concept of preconception care has evolved in the
health care community, several professional organizations
have addressed its importance for their members, and some
have developed specific guidelines or standards for precon-
ception care.
Nursing organizations
In nursing, there are several professional organizations
whose members care for reproductive age women. The
AANP (American Academy of Nurse Practitioners) is the
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largest national professional organization for nurse practi-
tioners of all specialties, with 15,000 members. While many
nurse practitioners might be delivering preconception health
services, AANP has not developed specific educational
standards specific to this topical area, nor do their generic
practice standards include preconception health. According
to AANP Executive Director Dr. Judith Dempster (personal
communication, April 11, 2005), members with questions
about preconception health standards would be referred to
specialty organizations such as AWHONN.
AWHONN (Association of Women’s Health, Obstetric
and Neonatal Nurses) is the official professional organiza-
tion for women’s health and obstetric nurses, and is com-
prised of 22,000 nurses whose goals are to promote excel-
lence in nursing practice. While AWHONN does not have
specific standards of care for women during the precon-
ception period, they do offer many products to their mem-
bers which discuss preconception health, including a practice
monograph which outlines the importance and components
of preconception care [16]. They also publish a Clinical
Position Statement which states that AWHONN supports
legislation and policies that encourage women of childbear-
ing age to consume 400 micrograms of synthetic folic acid
every day [17]. In addition, AWHONN is also a member of
the National Council on Folic Acid (NCFA), a partnership of
over 80 national organizations and associations, state folic
acid councils and government agencies. While not strictly
a preconceptional project, AWHONN developed a specific
Clinical Position Statement on Smoking and Childbearing,
urging nurses to screen women for tobacco use and help
women stop smoking [18]. Although nurses initiated this
program during pregnancy, it had major interconceptional
ramifications for the women involved, and has added to the
literature on smoking cessation for women of reproductive
age [19].
ACNM, the American College of Nurse Midwives is
the professional organization for all nurse midwives in
the United States, and represents over 7,000 nurse mid-
wives who are providers of comprehensive women’s health.
In their Core Competencies for Basic Midwifery Practice
(www.acnm.org/prof/display.cfm?id = 137) they have spe-
cific educational and practice standards for preconception
health for women. These standards are:
“V. Components of Midwifery Care: The Primary Health
Care of Women
B. Applies knowledge of midwifery practice in the pre-
conception period that includes, but is not limited to, the
following:
1. Assessment of individual and family readiness for preg-
nancy, including emotional, psychosocial and sexual fac-
tors
2. Impact of health, family and genetic history on preg-
nancy outcomes
3. Influence of environmental and occupational factors,
health habits, and behavior on pregnancy planning
4. Health and laboratory screening to evaluate the poten-
tial for a healthy pregnancy” (p. 3)
NAPNAP (the National Association of Pediatric Nurse
Practitioners) does not publish any guidelines or standards
for preconception care. Their members provide services for
adolescents, but the organization has not yet addressed pre-
conception care in a structured manner (personal commu-
nication Dr. Karen Kelly Thomas, Executive Director NAP-
NAP, April 13, 2005). They have, however, published at least
one article in their official journal on the topic [20].
In terms of general nursing education, the AACN (The
American Association of Colleges of Nursing) does not of-
fer specific guidelines for what is to be taught to student
nurses about preconception health, but rather sets standards
for overall educational goals.
Organizations for all professionals
The March of Dimes, while not an organization which targets
just one type of professional, has been producing numerous
materials for health care professionals about preconcep-
tion health for many years. Materials and products that the
March of Dimes produces for providers of care include: their
nursing module Preconception Health Promotion: A Focus
for Women’s Wellness [21], a Preconception Curriculum
consisting of power point slides for Obstetricians, Family
Medicine specialists, Pediatricians, and Internists which
suggests that every visit to a health care provider should
include elements of preconception care, a Preconception
Screening and Counseling Tool, grants to the March of
Dimes Chapters for preconception services, an educational
program called Genetics and Your Practice (CD and online),
and a Genetic screening pocket guide. Many of these can
be found on their website www.marchofdimes.com, and
their Spanish language website www.nacersano.org. They
also produce an e-preconception newsletter (Spanish), an
education program for Spanish women called Comenzando
Bien, and pamphlets for patient education such as Are
You Ready?, Think Ahead for a Healthy Baby, Folic Acid
brochures, and Pre-Pregnancy Planning Fact Sheet.
The CDC, the March of Dimes, and the National Council
on Folic Acid (NCFA) have organized a national folic acid
promotion effort for the prevention of serious birth defects
of the brain and spine (neural tube defects or NTDs).
The goal of the effort is to teach all women about the
importance of getting enough folic acid every day. The
effort aims to reach every woman who could possibly
Springer
S48 Matern Child Health J (2006) 10:S43–S52
become pregnant, as well as teach health care professionals
and community advocacy groups about the importance of
folic acid. The CDC, the March of Dimes, and NCFA have
created messages, materials, websites, and other tools to
reach providers and women with the folic acid message.
In 2005, the CDC and March of Dimes collaborated to
develop a national summit on preconception care in order
to bring together all the stakeholders in the subject; this
supplement issue of Maternal Child Health is one of the
many consequences of these efforts by CDC/MOD.
Physician organizations
The American Academy of Pediatrics represents 60,000 pe-
diatricians, many of whom provide adolescent services to
young women of reproductive age. They publish, along with
the American College of Obstetricians and Gynecologists,
Guidelines for Perinatal Care, the document which is gen-
erally accepted to be the outline for acceptable care during
the perinatal period for women and infants. In the current
edition, 5 pages are devoted to preconception care, which is
described as “the identification of those conditions that could
affect a future pregnancy or fetus, and that may be amenable
to intervention (p. 73)” [14]. The Guidelines note that all
encounters with women of reproductive age should include
counseling about health which could optimize pregnancy
outcome. AAP is also a member of the National Organiza-
tion on Fetal Alcohol Syndrome, which addresses medical
school curriculum for fetal alcohol syndrome, and AAP sup-
ports numerous state-wide programs to enhance adolescent
health before childbearing. In the American Board of Pedi-
atrics study guide for the certifying examining for Adoles-
cent Medicine certification, materials included are preven-
tion of pregnancy, prevention of substance use, and general
reproductive health care, all of which contribute to better
preconception health (www.aap.org/sections/adol/adol.pdf).
The American Academy of Family Physicians (AAFP)
represents 94,000 family physicians, residents and medi-
cal students in the United States, and sets the professional
standards for care delivered by family physicians. While no
specific guidelines or standards for preconception health ser-
vices developed by AAFP could be located, AAFP addresses
the issue of preconception care in many articles in their offi-
cial journal, and in other practice venues such as suggestions
to increase use of folic acid [22, 23].
CREOG is the Council on Resident Education in Ob-
stetrics and Gynecology, and is charged with setting the
educational standards for obstetricians and gynecologists
in training. CREOG’s Educational Objectives are contained
in its core curriculum [24]. Regarding preconception care,
CREOG’s core curriculum states: “In evaluating patients for
preconceptional care, obstetrician gynecologists must assess
those factors of the history, physical examination, and di-
agnostic studies that pregnancy would alter; assess the pa-
tient’s access to and compliance with a plan of prenatal care;
and consult with or refer her to other experts on specific
conditions that may arise during the pregnancy.”(p. 39). Its
standards are as follows:
“ II. Antepartum Care—Preconceptional Care
1. Perform a thorough history, assessing historical and
ongoing risks that my affect future pregnancy
2. Counsel a patient regarding the impact of pregnancy on
maternal medical conditions.
3. Counsel a patient regarding the impact of maternal
medical conditions on pregnancy
4. Counsel a patient regarding appropriate lifestyle mod-
ification conducive to favorable pregnancy outcome.
5. Counsel a patient regarding appropriate preconception
testing.
6. Counsel a patient regarding pregnancy associated risks
and conditions, such as advanced age, hypertension, di-
abetes, genetic disorder, prior aneuploid or anomalous
fetus/newborn” (p. 49)
ACOG, the American College of Obstetricians and Gyne-
cologists represents 46,000 obstetricians and gynecologists
in the United States, and in 2005 celebrated its 50th anniver-
sary. ACOG has advocated for preconception care for sev-
eral decades, and offers the most detailed guidelines for the
provision of preconception services. ACOG’s acknowledges
that while ideal health prior to pregnancy does not guaran-
tee a perfect or uncomplicated pregnancy, women who are
considering pregnancy should undergo comprehensive pre-
conception evaluation, examination, and counseling. How-
ever, preconception care is best when it is provided as part
of primary health care, rather than as a discrete new cate-
gory of health care, particularly since almost one-half of all
pregnancies in the United States are unintended [25, 26].
Components of preconception care—ACOG
In examining multiple documents produced by ACOG in
recent years, certain components of preconception care can
be delineated.
Periodic assessments
Preconception counseling should occur at periodic assess-
ments for all reproductively capable women. These assess-
ments may be yearly or as appropriate [27]. Counseling
should include discussions about the likelihood of pregnancy
(planned or unplanned), counseling on appropriate medical
care and behavior to optimize pregnancy outcomes, specific
Springer
Matern Child Health J (2006) 10:S43–S52 S49
health risks the woman has that may predispose her to an ad-
verse pregnancy outcome if not addressed, and how to either
effectively prevent an unplanned pregnancy or to maximize
her physical and emotional health prior to a planned or even
unplanned event. Even clinicians that do not provide prenatal
care should be able to provide preconception counseling and
screening to their reproductively capable patients.
The patient’s history should be reviewed and updated on
an annual basis or more often if appropriate. The history
should include a review of any medical conditions and med-
ications the patient may be using. It is important to ask about
prescription as well as over the counter drugs, herbs, and sup-
plements. Inquiries about occupational and hobby exposures
to chemicals, solvents, or heavy metals should be made. In
this manner, potentially teratogenic agents may be identified.
The patient’s reproductive history may provide impor-
tant clues about future pregnancy risks. Recurrent miscar-
riages should raise suspicion of a possible genetic or chro-
mosomal problem. The neonatal outcome of previous preg-
nancies should be noted but it is equally as important to
ask women about the current health of any children they
have as some congenital disorders do not become mani-
fest until several months or even years after birth and may
not be considered by the family to represent a congenital
defect.
Genetic disorders and genetic screening
The woman’s family history and ethnicity for genetic disor-
ders and malformations should be obtained. Carrier screen-
ing for Tay-Sachs disease is recommended for individuals
of Eastern European (Ashkenazi) Jewish, French Canadian
and Cajun descent [28]. ACOG recommends offering cys-
tic fibrosis screening to individuals with a family history,
reproductive partners of persons with cystic fibrosis, and to
couples in whom one or both partners are Caucasian and are
planning pregnancy [29].
Carrier screening for Tay-Sachs, Canavan disease, cys-
tic fibrosis, and familial dysautonomia should be offered to
Ashkenazi Jewish individuals during preconception screen-
ing. These same individuals may be offered or may request
screening for Gaucher disease, Niemann-Pick disease type
A, Fanconi anemia group C, Bloom syndrome, or mucol-
ipidosis IV as well. Carrier screening should be offered to
any individual with a positive family history of one of these
disorders; the screening should be for the specific disorder.
When only one partner is of Ashkenazi Jewish descent, that
individual should be screened first. Except for Tay-Sachs and
cystic fibrosis, the carrier frequency and detection rate for
the other disorders is unknown.
If an individual is found to be a carrier for Tay-Sachs or
one of the other aforementioned diseases, their relatives are at
risk for carrying the same mutation; carriers are encouraged
to inform their relatives of the risk and availability of carrier
screening [28].
Other screening tests exist for genetic disorders with an
increased incidence in specific ethnic groups, e.g., alpha or
beta thalassemia screening in Orientals, beta thalassemia
screening for those of Mediterranean descent, and sickle
cell disease screening for African-Americans.
Women who have had a previous pregnancy complicated
by autosomal trisomy, a sex chromosome aneuploidy, or if
either partner has a chromosome translocation or inversion or
aneuploidy should be given education about their increased
risk of recurrence in future pregnancies and a referral for
pre-pregnancy genetic counseling should be offered [30].
Immunizations and infectious diseases
The woman’s immunization status, history of childhood dis-
eases, and risk for exposure to hepatitis, HIV, or other sex-
ually transmitted infections needs to be updated at least
annually. When practical, preconceptional immunization of
women to prevent disease in the offspring is preferred to
vaccination of pregnant women with certain vaccines [31].
Approximately 30% of US adults have serologic evidence
of prior exposure to toxoplasma gondii, a known teratogen.
Screening for Toxoplasma gondii is controversial because
evidence that treatment prevents congenital disease is lack-
ing. All reproductively capable women should be advised to
avoid eating undercooked or raw meat, wear gloves when
working with soil, and practice safe-handling techniques
when changing cat litter [32].
Congenital cytomegalovirus (CMV) infection occurs in
1% of all live births in the United States and causes ma-
jor neonatal illness in 5% to 10% of these cases. Women
with young children or those who work with young children
may be counseled about reducing the risk of CMV through
universal precautions, e.g. the use of latex gloves and rigor-
ous hand-washing after handling diapers or after exposure
to respiratory secretions. There are currently no other spe-
cific recommendations as there is no evidence that screening
and/or treatment programs prevent infection [32, 33].
All women should be kept current with age-appropriate
vaccines. Reproductive aged women should be asked about
previous infection with varicella and offered vaccination if
they report no known history of chickenpox. Conception
should be delayed until 1 month after the second injection is
given. Women who expect to be at least 3 months pregnant
during the influenza season (November to April) should be
vaccinated.
Behavioral/psychosocial factors
A woman’s lifestyle and social behaviors should be re-
viewed and updated frequently. The use of alcohol, smoking,
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or other substances may have significant effects on preg-
nancy. Smoking during pregnancy is associated with low
birth weight, abruptio placenta, preeclampsia, and preterm
labor [34]. A woman’s personal situation has a significant
effect on her health and often changes over time. Clinicians
should ask all women about intimate partner violence and
women should be aware that it may escalate during preg-
nancy. In addition, a woman’s mental health history may
provide clues about recurrence risks either during or after a
pregnancy.
A woman’s dietary habits should be reviewed. Daily folic
acid intake of 0.4 mg should begin at least 1 month be-
fore pregnancy and continue through the first trimester. For
women who have had a child with a neural tube defect, a
higher dose of folic acid (4.0 mg/d) is recommended and has
been shown to decrease the recurrence rate of neural tube
defects [35]. Women who may become pregnant—planned
or unplanned—should be aware of recent FDA warnings to
avoid specific types of fish as they may be high in methyl
mercury—a known neurotoxin to a developing fetal nervous
system. Women should also be questioned about the need for
any dietary restrictions they may have required in childhood.
Women with PKU in childhood may not currently be adher-
ing to a phenylalanine free diet but hyperphenylananinemia
is associated with neurological impairment in a developing
fetus.
Maternal prepregnancy weight is associated with several
adverse outcomes. Women weighing more than >300 lbs
(>136 kg) prior to pregnancy have a markedly increased
risk for developing gestational diabetes, preeclampsia, and
requiring a cesarean delivery compared with women weigh-
ing 100–149 lbs (45–67 kg). In one study, even among a
subsample of women who did not have any diabetic or hy-
pertensive diseases, excess weight significantly increased the
likelihood of macrosomia and NICU treatment [36]. The re-
lationship between maternal obesity and perinatal outcomes
is necessary when discussing routine care as well as specific
preconception planning.
Medical history and conditions
While most reproductive aged women are healthy, there are
specific medical conditions associated with adverse preg-
nancy outcomes if untreated or treated poorly. Some medical
conditions are contraindications to pregnancy. Hypertension
should be under control prior to initiation of a pregnancy
and women using angiotensin-converting enzyme inhibitors
and angiotensin II receptor antagonists who are considering
pregnancy should be switched to other agents and adjusted on
these medications prior to conception. Certain cardiac disor-
ders, such as primary pulmonary hypertension, place women
at a very high risk for morbidity or mortality during preg-
nancy [37]. There is an increased risk (3–10%, depending
on the parent’s condition) of congenital heart disease among
children born to women who have a history of a congenital
heard defect [38].
Women with a history of thromboembolism have an in-
creased risk of recurrence during pregnancy. Women with a
history of thrombosis should be offered testing for inherited
or acquired thrombophilias, particularly if the results of the
testing would affect the management of future pregnancies.
Testing may be considered in women with a family history of
thrombosis or a first degree relative with a specific mutation
[39].
It is very important that women receive a thorough work-
up and evaluation prior to being diagnosed with a seizure
disorder and started on medication. Women diagnosed with
seizures of unknown etiology should be told that even if they
are on no medications at all, they have a two-fold higher
risk for congenital malformations in their offspring than
individuals without seizures. Anticonvulsant therapy use
during pregnancy, particularly hydantoin or valproic acid,
is associated with an increased risk for specific congenital
defects. It is important to determine if anticonvulsant med-
ication can be safely discontinued or to initiate therapeutic
changes before pregnancy occurs. Women should be told
that enzyme-inducing antiepileptic drugs may lower the
efficacy of combination oral contraceptives, so an oral
contraceptive containing a higher estrogenic concentration
may be necessary. For women taking antiepileptic drugs
who are considering a pregnancy, folic acid supplementation
5 mg/day is recommended for one month prior to conception
and until the end of the first trimester [40].
Women with poorly controlled asthma before pregnancy
tend to have increased difficulty with asthma during preg-
nancy [41]. Severe, poorly controlled asthma may have an
adverse effect on fetal outcome as a result of chronic or
intermittent maternal hypoxaemia [42].
Women with quiescent autoimmune disease or a distant
history of disease should be carefully evaluated and coun-
seled about maternal and fetal risks. Patients should be coun-
seled that the best time to attempt conception is during peri-
ods of inactive disease.
Women should be made aware of the deleterious effects
of hypothyroidism in pregnancy, including an increased in-
cidence of abortion, obstetric complications and fetal abnor-
malities in untreated women [43, 44]. Women being treated
for hypothyroidism will require increased doses of thyroxine
early and throughout pregnancy in order to maintain adequate
levels; this is especially important during the first trimester
[45]. Low maternal thyroxine concentrations may lead to
impaired neurodevelopmental outcome in the neonate and
child. Routine assessment for the presence of subclinical
hypothyroidism is not recommended. ACOG recommends
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testing of thyroid function only in women with a personal
history of thyroid disease or symptoms of thyroid disease
[46].
Diabetes mellitus represents a medical condition where
preconception control has been proven to translate into im-
proved maternal-fetal outcomes. Patients with poor glucose
control during the first 8–10 weeks of pregnancy have a 2–3
fold higher risk of birth defects in their offspring than patients
without diabetes. Good glycemic control before conception
diminishes the risk of birth defects to a level comparable to
that of the normal population [47].
Women should be asked about any ongoing dermato-
logic therapy she may be receiving. Isotretinoin (Accu-
tane) is used for a variety of skin conditions and is a
known teratogen. Some anti-psoriasis treatments (Acetretin
X and methotrexate) are known teratogens, while some an-
tiviral medications (podophyllum) are contraindicated in
pregnancy.
Table 1 includes suggestions for the clinician during rou-
tine or periodic health assessments to optimize possible
future pregnancy outcomes for all reproductively capable
women.
Table 1 Suggestions for the clinician during routine or periodic
health assessments to optimize possible future pregnancy outcomes for
all reproductively capable women
 Determine if the woman suffers from any undiagnosed or
uncontrolled medical problems. If she does, provide
recommendations for treatment of these conditions and when it
would be best to attempt pregnancy.
 Make sure the patient is aware of any associations between the
medical condition(s) and medications(s) she is taking and their
impact on pregnancy outcomes.
 Ask the woman about her reproductive intentions at every visit,
ascertain what her risk of an unplanned pregnancy may be; for
women not actively seeking to become pregnant, discuss her
current contraceptive method and any concerns or problems she
may be having with it.
 Review the woman’s family history—including new births among
family members—annually as things change over time. Discuss
any familial conditions that may herald an increased risk of
adverse pregnancy outcome for the woman.
 Discuss the significance that nutrition can have on maternal fetal
outcomes,e.g., the impact of 0.4 mg folic acid per day on neural
tube defects in women with no family or previous history of a
neural tube defect), the need to avoid excessive vitamin usage,
especially vitamins A and D, and the additional measures women
on restricted diets may need to take to optimize their health and
the health of the developing fetus.
 Review the patient’s social behaviors or lifestyle patterns—such
as smoking, alcohol, or other substance use or abuse—that may
affect pregnancy adversely and offer treatment options.
 Ascertain the immunity status of woman to rubella, hepatitis, and
varicella. Ensure she is up to date on immunizations.
Conclusion
The concept of preconception care has gained momentum
over the past two decades, and health care providers are
increasingly being urged to provide such care by their pro-
fessional organizations. It is hoped that, with its stated goal
of improving birth outcomes, preconception care could help
insure that the health status of all reproductively capable
women would be optimized. In examining available stan-
dards and guidelines for preconception care, the professional
nursing organization with the most highly developed precon-
ception health standards is the American Academy of Nurse
Midwives, and for physicians is the American College of
Obstetricians and Gynecologists [48]. Other professional or-
ganizations examined did not have specific care standards
for comprehensive preconception health, but have educated
their members about one or more aspects of preconception
health (smoking cessation, folic acid awareness).
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